**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| Not available |1-(Gamma-Hydroxypropyl)-6,7-Dimethoxy-| ca. 100 | unlisted |
| |1,2,3,4-Tetrahydroisoquinoline Hydroch| | |
| |loride | | |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: C
Risk Phrases: 34
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Causes burns.Corrosive.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal
damage.
Skin:
Causes skin burns. May cause skin rash (in milder cases), and cold
and clammy skin with cyanosis or pale color.
Ingestion:
May cause severe and permanent damage to the digestive tract. Causes
gastrointestinal tract burns. May cause perforation of the digestive
tract. The toxicological properties of this substance have not been
fully investigated. May cause systemic effects.
Inhalation:
Causes chemical burns to the respiratory tract. The toxicological
properties of this substance have not been fully investigated.
Aspiration may lead to pulmonary edema. May cause systemic effects.
May cause Central Nervous System Effects characterized by apathy,
mental confusion, blurred vision, and tremors.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Get medical aid immediately. Do NOT allow victim to rub eyes or keep
eyes closed. Extensive irrigation with water is required (at least 30
minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Containers
may explode in the heat of a fire.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Minimize dust generation and accumulation. Do not breathe dust,
vapor, mist, or gas. Do not get in eyes, on skin, or on clothing.
Keep container tightly closed. Do not ingest or inhale. Use only in
a chemical fume hood. Discard contaminated shoes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 0-01-1:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 166 - 169 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density:
Molecular Formula: C14H22ClNO3
Molecular Weight: 287.79
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 0-01-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(Gamma-Hydroxypropyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
Hydrochloride -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 25 Avoid contact with eyes.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 0-01-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 0-01-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 0-01-1 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/23/1998 Revision #4 Date: 12/21/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-(Piperidylmethyl)-1-Cyclohexanone Hydrochloride, 98%
| 6966-09-2 |
|
Fluorosilicic Acid (25 Wt % Aqueous Solution)
| 7732-18-5 |
|
(S)-(-)-Bupivacaine hydrochloride, 99%
| 27262-48-2 |
|
6,7-Diethoxy-3,4-Dihydroisoquinoline-1(2H)-Thione, 98%
| 0-01-1 |
|
Sodium phosphate, dibasic anhydrous, reagent ACS
| 7558-79-4 |
|
1-Nonanol
| 143-08-8 |
|
2-Acetyl-6,7-Dimethoxy-1-Methylene-1,2,3,4-Tetrahydroisoquinoline,
| 57621-04-2 |
|
Lithium methoxide, 10% solution in methanol
| 865-34-9 |
|
[(3S)-4-Azabicyclo[4.4.0]Dec-3-yl]-N-(Tert-Butyl)Carboxamide, 99%
| 136465-81-1 |
|
C-Benzylcalix(4)resorcinarene
| 0-01-1 |
|
(S)-(-)-2-(2'-Carbomethoxyethyl)-2-Methyl-Cyclohexanone, 98.5+%
| 112898-44-9 |
|
(S)-(-)-alpha-Amino-gamma-butyrolactone hydrochloride, 98%
| 2185-03-7 |
|
N-Benzylmaleimide
| 1631-26-1 |
|
4-(Methylamino)benzoic acid, 97%
| 10541-83-0 |
|
Ethyl (3S)-3-Hydroxybutyrate, 99%
| 56816-01-4 |
|
Hydrofluoric Acid (48-51%), Reagent ACS
| 7664-39-3 |
|
ETHYL (1R,2S)-2-HYDROXYCYCLOHEXANECARBOXYLATE
| 61586-78-5 |
|
Iodic Acid, Reagent ACS (Crystals), 99.5% (Titr.)
| 7782-68-5 |
|
3-Pyrazolidinone Hydrochloride
| 1752-88-1 |
|
Tritylphenol
| 978-86-9 |
|
4-Hydroxy-2-Methoxybenzaldehyde, 98%
| 18278-34-7 |
|
4-Nitrobiphenyl, 98%
| 92-93-3 |
|
6-Iodo-2-picolin-5-ol, 97%
| 23003-30-7 |
|
Ethyl
| 100491-29-0 |
|
D(+)-Carnitine, 98%
| 541-14-0 |
|
D(+)-Carnitinenitrile Chloride, 97%
| 0-01-1 |
|
5-Amino-o-Cresol, 97%
| 2835-95-2 |
|
Hydrogen Peroxide (30% in Water) (Without Stabilizer), Reagent ACS
| 7722-84-1 |
|
4-Amino-o-Cresol, 97%
| 2635-95-2 |
|
Hydroquinone, p.a.
| 123-31-9 |
|
2,3-Difluoro-6-nitrophenol, 97%
| 82419-26-9 |
|
Hydroxylamine Sulfate, 99%
| 10039-54-0 |
|
Hypophosphorous Acid, 50 wt% Solution in Water
| 7732-18-5 |
|
cis-2-Heptene, 97%
| 6443-92-1 |
|
Imidazole
| 288-32-4 |
|
3-Amino-3-Cyclohexylpropionic Acid, 98%
| 129042-71-3 |
|
3-Fluorophenylacetic Acid, 98%(GC)
| 331-25-9 |
|
3-Benzylaminobutyric Acid, 98%
| 14676-01-8 |
|
4-NITROTHIOPHENOL, TECH., 80+%
| 1849-36-1 |
|
ALPHA,ALPHA-DIPHENYLGLYCINE, 98%
| 3060-50-2 |
|
Zirconium(IV) ethoxide, 99%
| 18267-08-8 |
|
Celite high-purity analytical grade
| 61790-53-2 |
|
2-CYANOETHYLHYDRAZINE, 98%
| 353-07-1 |
|
Pentamethylbenzaldehyde, 96%
| 17432-38-1 |
|
4-Chloro-3-nitrobenzenesulfonic acid, sodium salt, 98% (tlc)
| 17691-19-9 |
|
cis-2-Benzylaminomethyl-1-Cyclohexanol Hydrochloride, 98%
| 77612-17-0 |
|
Iron, electrolytically reduced, reagent (powder)
| 7439-89-6 |
|
1-(Gamma-Hydroxypropyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
| 0-01-1 |
|
Iron (III) Oxide, 99.999%, -100 Mesh
| 1309-37-1 |
|
Perfluoroadipic acid hydrate, 98%
| 123334-02-1 |
|
|